ReviewFEMS microbiology reviews2025
Mechanisms conferring multi-layered protection against intestinal Salmonella Typhimurium infection.
Review in FEMS microbiology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Dietary conjugated linoleic acid enhances resistance toGut microbes · 2026Article
- Host-microbiota-pathogen interactions drive Salmonella enterica serovar Typhimurium pathogenesis.Nature reviews. Microbiology · 2026Review
- Infection strategies ofGut microbes reports · 2026Review
- Casein hydrolysate promotes intestinal repair in adult mice withFrontiers in immunology · 2026Article
- Dietary Pediocin Supplementation Restores Intestinal Barrier Function and Microbiota Balance inMicroorganisms · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Enteropathogens cause many gastrointestinal infections every year. However, it is often overlooked that many individuals remain asymptomatic despite exposure to these pathogens. The mechanisms underlying this effective protection against infection may hold important clues for disease prevention or therapy. Here, we focus on Salmonella enterica serovar Typhimurium (S. Tm), a well-studied enteropathogen closely related to commensal Escherichia coli. We discuss the host's multi-layered defence mechanisms that protect against S. Tm infection of the intestine, with an emphasis on the microbiota, epithelial barrier, and immune system. Perturbations in these defences, such as microbiota dysbiosis, variability in epithelial barrier integrity, or immune defects, can impair protection and increase susceptibility to disease. Additionally, we review the virulence mechanisms and metabolic adaptations that S. Tm has evolved to overcome these protective layers. This complex interplay between host defence layers and pathogen traits, shaped by both intrinsic and extrinsic factors, ultimately determines whether exposure results in asymptomatic carriage or symptomatic disease. Understanding these dynamics is critical for developing targeted interventions to prevent S. Tm infections and mitigate their impact on public health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.